These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. Hof PR; Cox K; Morrison JH J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex. Hof PR; Morrison JH J Comp Neurol; 1990 Nov; 301(1):55-64. PubMed ID: 1706358 [TBL] [Abstract][Full Text] [Related]
4. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA; Nafe R; Schlote W Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical phenotype of corticocortical connections in the macaque monkey: quantitative analysis of a subset of neurofilament protein-immunoreactive projection neurons in frontal, parietal, temporal, and cingulate cortices. Hof PR; Nimchinsky EA; Morrison JH J Comp Neurol; 1995 Nov; 362(1):109-33. PubMed ID: 8576425 [TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease. Vogt BA; Vogt LJ; Vrana KE; Gioia L; Meadows RS; Challa VR; Hof PR; Van Hoesen GW Exp Neurol; 1998 Sep; 153(1):8-22. PubMed ID: 9743563 [TBL] [Abstract][Full Text] [Related]
7. Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Bussière T; Gold G; Kövari E; Giannakopoulos P; Bouras C; Perl DP; Morrison JH; Hof PR Neuroscience; 2003; 117(3):577-92. PubMed ID: 12617964 [TBL] [Abstract][Full Text] [Related]
8. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease. Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767 [TBL] [Abstract][Full Text] [Related]
9. Neurofilament-immunoreactive neurons are not selectively vulnerable in Alzheimer's disease. Shepherd CE; Thiel E; McCann H; Halliday GM Neurobiol Dis; 2001 Feb; 8(1):136-46. PubMed ID: 11162247 [TBL] [Abstract][Full Text] [Related]
10. alpha-Internexin immunoreactivity reflects variable neuronal vulnerability in Alzheimer's disease and supports the role of the beta-amyloid plaques in inducing neuronal injury. Dickson TC; Chuckowree JA; Chuah MI; West AK; Vickers JC Neurobiol Dis; 2005 Mar; 18(2):286-95. PubMed ID: 15686957 [TBL] [Abstract][Full Text] [Related]
12. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease. Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic cytochrome c immunolabelling in dystrophic neurites in Alzheimer's disease. Woodhouse A; Vickers JC; Dickson TC Acta Neuropathol; 2006 Oct; 112(4):429-37. PubMed ID: 16855832 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. von Gunten A; Kövari E; Bussière T; Rivara CB; Gold G; Bouras C; Hof PR; Giannakopoulos P Neurobiol Aging; 2006 Feb; 27(2):270-7. PubMed ID: 16399212 [TBL] [Abstract][Full Text] [Related]
15. Life and death of neurons in the aging cerebral cortex. Morrison JH; Hof PR Int Rev Neurobiol; 2007; 81():41-57. PubMed ID: 17433917 [TBL] [Abstract][Full Text] [Related]
16. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. Campbell MJ; Morrison JH J Comp Neurol; 1989 Apr; 282(2):191-205. PubMed ID: 2496154 [TBL] [Abstract][Full Text] [Related]
18. Cortical selective vulnerability in motor neuron disease: a morphometric study. Maekawa S; Al-Sarraj S; Kibble M; Landau S; Parnavelas J; Cotter D; Everall I; Leigh PN Brain; 2004 Jun; 127(Pt 6):1237-51. PubMed ID: 15130949 [TBL] [Abstract][Full Text] [Related]
19. The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease. Iwai A; Masliah E; Sundsmo MP; DeTeresa R; Mallory M; Salmon DP; Saitoh T Brain Res; 1996 May; 720(1-2):230-4. PubMed ID: 8782917 [TBL] [Abstract][Full Text] [Related]
20. Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease. Saitoh T; Iimoto D Prog Clin Biol Res; 1989; 317():769-80. PubMed ID: 2690121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]